Commercial production

Commercial production
Product Description

Various manufacturing processes available and flexible batch sizes.
Each process is equipped with multiple production function rooms,and each function room adopts an independent HVAC system to minimizecross-contamination during manufacturing of multiple products.

Capacity: 13 billion tablets/capsules and 100 million bottles of oral liquids

Dosage forms available
Oral solids: tablets, hard capsules , granules, dry suspensions, powders, glucocorticoid solids etc.
Oral liquids: oral solutions, oral suspensions, syrups etc.
OEB4 high potent preparations.

Huayi Pharmaceuticals (Anhui) Co.,Ltd

  • Country/Region:
    China
  • On CPHI since:
    2021
  • Certificates:
    2
  • Employees:
    250 - 499
Company types
CMO/CDMO
Contract Service
Specifications
  • Selling Points
    Experienced Technicians

Huayi Pharmaceuticals (Anhui) Co.,Ltd

  • Country/Region:
    China
  • On CPHI since:
    2021
  • Certificates:
    2
  • Employees:
    250 - 499
Company types
CMO/CDMO
Contract Service

More Products from Huayi Pharmaceuticals (Anhui) Co.,Ltd (2)

  • Pharmaceutical Development

    Product Pharmaceutical Development

    Meet customers’ diversified demands for R&D
    Provide customers with comprehensive support from R&D to manufacturing, covering multiple dosage form development, including solid preparation (tablets, capsules, granules), liquid preparations (oral solutions, injections), and semi-solid preparati...
  • Licensing out

    Product Licensing out

    Licensing out after successful development.

Huayi Pharmaceuticals (Anhui) Co.,Ltd resources (2)

  • News Huayi passed remote GMP re-inspection by MHRA

    On 23rd June, 2021, Huayi passed remote GMP re-inspection by MHRA including new workshops for moderately potency product and oral liquid.
  • Video Huayi Pharmaceuticals

    Huayi Pharmaceutical (Anhui) Co. Ltd. is an EU cGMP approved Sino-British joint venture located in Hefei, Eastern China. We manufacture quality generic medicines on a contractual basis for EU and Chinese customers with competitive pricing.